SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-032075
Filing Date
2012-05-02
Accepted
2012-05-02 17:05:43
Documents
2
Period of Report
2012-04-30

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 9511
2 EX-24 ex-24.htm EX-24 4998
  Complete submission text file 0001104659-12-032075.txt   15839
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA TESSERETE, 10 LUGANO V8 V8
Business Address
CAVAZZA PAOLO (Reporting) CIK: 0001163608 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 12806223